Pulmonary Disease Chronic Obstructive Therapy
Mostrando 1-12 de 46 artigos, teses e dissertações.
-
1. Evaluating the disease and treatment information provided to patients with chronic obstructive pulmonary disease at the time of discharge according to GOLD discharge guidelines
RESUMO Objetivo Avaliar informações sobre a doença e o tratamento fornecidos a pacientes com doença pulmonar obstrutiva crônica no momento da alta hospitalar. Métodos Estudo transversal incluindo pacientes internados com doença pulmonar obstrutiva crônica de três hospitais terciários. O estudo baseou-se em sete itens das diretrizes de alta hospit
Einstein (São Paulo). Publicado em: 09/12/2019
-
2. Eficácia e segurança da oxigenoterapia com cânula nasal de alto fluxo na insuficiência respiratória hipercápnica moderada aguda
RESUMO Objetivo: Avaliar a eficácia e a segurança da oxigenoterapia com uso de cânula nasal de alto fluxo no tratamento da insuficiência respiratória hipercápnica moderada em pacientes que não conseguem tolerar ou têm contraindicações para ventilação mecânica não invasiva. Métodos: Estudo prospectivo observacional de 13 meses envolvendo part
Rev. bras. ter. intensiva. Publicado em: 23/05/2019
-
3. Characteristics of long-term home oxygen therapy users in the municipality of Curitiba, Brazil
Resumo Introdução: No tratamento e prevenção de doenças pulmonares crônica, o uso da Oxigenoterapia Domiciliar Prolongada (ODP) mostra-se favorável, pois melhora a qualidade de vida, aumenta sobrevida e reduz períodos de hospitalização. No entanto, os autores desconhecem estudos descritivos que relatem o perfil clínico e social dos pacientes que
Fisioter. mov.. Publicado em: 21/02/2019
-
4. Influence of Pulmonary Rehabilitation on Clinical Characteristics in Patients with Chronic Heart Failure and Chronic Obstructive Pulmonary Disease
Abstract Background: The improvement of treatment strategies in patients with chronic obstructive pulmonary disease (COPD) and especially with comorbid pathology should provide rational conversion of standard schemes of therapy and rehabilitation in accordance with their clinical, pathogenic, functional and economic feasibility. Objective: To assess the in
Int. J. Cardiovasc. Sci.. Publicado em: 30/07/2018
-
5. Analysis of risk factors and clinical manifestations associated with Clostridium difficile disease in Serbian hospitalized patients
Abstract Clostridium difficile is the leading cause of infectious diarrhoea in hospitalized patients. The aim of this study was to determine the risk factors important for the development of hospital-acquired Clostridium difficile-associated disease and clinical manifestations of Clostridium difficile-associated disease. The clinical trial group included 37
Braz. J. Microbiol.. Publicado em: 2016-12
-
6. Functional outcomes in patients with chronic obstructive pulmonary disease: a multivariate analysis
Background: Multiple factors can influence the severity of chronic obstructive pulmonary disease (COPD) and the functioning of patients with COPD, such as personal characteristics and systemic manifestations. Objective: To evaluate the different factors that can influence the activity and psychosocial impact domains of the Saint George's Respiratory Qu
Braz. J. Phys. Ther.. Publicado em: 2014-01
-
7. Acute effects of transcutaneous electrical diaphragmatic stimulation on respiratory pattern in COPD patients: cross-sectional and comparative clinical trial
BACKGROUND: Transcutaneous electrical diaphragmatic stimulation (TEDS) has been used to improve respiratory muscle strength in patients with respiratory muscle weakness. However, this physical therapy resource has not been studied in chronic obstructive pulmonary disease (COPD). OBJECTIVE: To evaluate the respiratory pattern during one session of TEDS
Braz. J. Phys. Ther.. Publicado em: 2013-11
-
8. Phase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: follow-up of up to 3 years
BACKGROUND Chronic obstructive pulmonary disease is a major inflammatory disease of the airways and an enormous therapeutic challenge. Within the spectrum of chronic obstructive pulmonary disease, pulmonary emphysema is characterized by the destruction of the alveolar walls with an increase in the air spaces distal to the terminal bronchioles but without si
Rev. Bras. Hematol. Hemoter.. Publicado em: 2013
-
9. Comment on: Phase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: follow-up of up to 3 years
Rev. Bras. Hematol. Hemoter.. Publicado em: 2013
-
10. Impacto da reabilitaÃÃo pulmonar nos marcadores inflamatÃrios prÃ-operatÃrios e nas complicaÃÃes pulmonares pÃs-operatÃrias de pacientes com cÃncer de pulmÃo candidatos a ressecÃÃo pulmonar / Impact of pulmonary rehabilitation in inflammatory markers in preoperative and postoperative pulmonary complications in patients with lung cancer candidates in pulmonary resection
Lung cancer (LC) is a malignant aggression which can be also surgically treated characterized by inflammation and higher mortality rates. Pulmonary complications are still concerning. The choice of studying fibrinogen and albumin is due to the fact that they are active inflammatory markers in LC often associated with chronic obstructive pulmonary disease. Pu
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 23/11/2011
-
11. Aspergilose invasiva em pacientes com doença pulmonar obstrutiva crônica internados em unidade de terapia intensiva
Recent data have suggested that chronic obstructive pulmonary disease (COPD) may be an important risk factor for invasive aspergillosis (IA), particularly in the context of mechanical ventilation (MV) and therapy with corticosteroids. Here we present the results of a prospective multicentric study (2009-2010) conducted in three intensive care units (ICUs) in
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 2011
-
12. Comparação entre a azitromicina e a amoxicilina no tratamento da exacerbação infecciosa da doença pulmonar obstrutiva crônica
Objetivo: Comparar a eficácia, segurança e tolerabilidade da azitromicina e da amoxicilina no tratamento de pacientes com quadro clínico de exacerbação infecciosa da doença pulmonar obstrutiva crônica. Métodos: Seis centros brasileiros incluíram 109 pacientes com idades entre 33 e 82 anos. Desses pacientes, 102 foram randomizados para receber azitro
Publicado em: 2010